Home › Funds › BVF INC/IL › ZYME

BVF INC/IL position in ZYME

ZYMEWORKS INC · Health Care

BVF INC/IL reported holding 3,649,142 shares of ZYME (ZYMEWORKS INC) in its Q2 2026 13F filing — a position valued at US$95.4M, representing 2.44% of its reported portfolio and ranking #14 among its reported holdings. BVF INC/IL has disclosed ZYME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.65M sh
Reported value held$95.39M
Portfolio Weight2.44%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's ZYME position evolved

BVF INC/IL first disclosed a stake in ZYME in Q3 2023 at 5,870,000 shares (US$37.2M). The position peaked in Q4 2025 at 3,938,641 shares, worth US$103.7M. Across 12 filings, BVF INC/IL increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 3,649,142 shares valued at US$95.4M — a reduction of -85,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.87M $37.22M New
Q4 2023 5.87M $60.99M Hold
Q1 2024 5.87M $61.75M Hold
Q2 2024 5.87M $49.95M Hold
Q3 2024 4.61M $57.83M Reduce
Q4 2024 4.31M $63.08M Reduce
Q1 2025 4.31M $51.32M Hold
Q2 2025 4.31M $54.08M Hold
Q3 2025 3.94M $67.27M Reduce
Q4 2025 3.94M $103.70M Hold
Q1 2026 3.73M $93.50M Reduce
Q2 2026 3.65M $95.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZYME and 13F data

ZYME (ZYMEWORKS INC) is a Health Care company. 30 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$600.4M), Rubric Capital Management LP (US$183.0M), PERCEPTIVE ADVISORS LLC (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZYME

All ZYME fund holders →

FAQ

How long has BVF INC/IL held ZYME?

BVF INC/IL has disclosed ZYME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BVF INC/IL's current position in ZYME?

As of Q2 2026, BVF INC/IL holds 3.65M shares of ZYME (ZYMEWORKS INC), valued at $95.39M, representing 2.44% of its reported portfolio and ranking #14.

Has BVF INC/IL been buying or selling ZYME?

In the latest 13F filing (Q2 2026), BVF INC/IL reduced its position in ZYME. The position peaked in Q4 2025 at 3.94M shares.

Which other funds hold ZYME?

Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.